"ZNA Middelheim is het grootste algemeen ziekenhuis van Antwerpen. Het ziekenhuis is actief in zowat alle medische domeinen. ZNA Middelheim biedt de meest diverse technische en bloedonderzoeken. Je kan er onze specialisten raadplegen in de polikliniek, opgenomen worden in het ziekenhuis of een behandeling krijgen in het dagziekenhuis."

During the past decade, ZNA Middelheim conducted 92 clinical trials. In the 10-year time frame, 92 clinical trials started and 36 clinical trials were completed, i.e. on average, 39.1% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 23 clinical trials were completed. i.e. 52.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ZNA Middelheim" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 30 trials, followed by "Pfizer" with 8 trials sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored, "Elixir Medical Corporation" with 6 trials sponsored and "Hoffmann-La Roche" with 6 trials sponsored. Other sponsors include 141 different institutions and companies that sponsored additional 113 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ZNA Middelheim" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Universiteit Antwerpen" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator. Other collaborators include 100 different institutions and companies that were collaborators in the rest 99 trials.

According to Clinical.Site data, the most researched conditions in "ZNA Middelheim" are "Coronary Artery Disease" (22 trials), "Atrial Fibrillation" (11 trials), "Leukemia" (9 trials), "Myelodysplastic Syndromes" (9 trials) and "Lymphoma" (6 trials). Many other conditions were trialed in "ZNA Middelheim" in a lesser frequency.

Most popular intervention types in "ZNA Middelheim" are "Drug" (115 trials), "Device" (58 trials), "Procedure" (26 trials), "Radiation" (20 trials) and "Biological" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "radiation therapy" (15 trials), "cytarabine" (8 trials), "cisplatin" (7 trials) and "allogeneic bone marrow transplantation" (6 trials). Other intervention names were less common.

The vast majority of trials in "ZNA Middelheim" are 180 trials for "All" genders, 12 trials for "Male" genders and 11 trials for "Female" genders.

Currently, there are 57 active trials in "ZNA Middelheim". 1 are not yet recruiting, 30 are recruiting, 25 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 97 completed trials in ZNA Middelheim, undefined suspended trials, and 27 terminated clinical trials to date.

Out of the total trials that were conducted in ZNA Middelheim, 2 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 47 trials that are defined as “Not Applicable".